http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018008914-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afcfc7af43784847a2171ad49795c3c3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553 |
| filingDate | 2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_216f1880e3fd8760c361fdefd11c400f |
| publicationDate | 2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018008914-A |
| titleOfInvention | Anti-brain tumor agent and pharmaceutical composition for treatment of brain tumor |
| abstract | Disclosed is a novel anti-brain tumor agent having high specificity for brain tumors. The anti-brain tumor agent of the present invention contains amoxapine or a pharmaceutically acceptable salt thereof as an active ingredient. [Selection figure] None |
| priorityDate | 2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.